Vincerx Pharma | 10-Q: Quarterly report
Vincerx Pharma | 8-K: Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
Vincerx Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Prosight Management, LP(9.1%),Prosight Partners, LLC(9.1%), etc.
Vincerx Pharma | 424B5: Prospectus
Vincerx Pharma | 8-K: Current report
Vincerx Pharma | 8-K: Current report
Vincerx Pharma | 424B5: Prospectus
Vincerx Pharma | ARS: Annual Report to Security Holders
Vincerx Pharma | DEFA14A: Others
Vincerx Pharma | DEF 14A: Definitive information statements
Vincerx Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(3.0 %),GOLDMAN SACHS & CO. LLC(3.0 %)
Vincerx Pharma | 8-K: Current report
Vincerx Pharma | 8-K: Current report
Vincerx Pharma | 424B5: Prospectus
Vincerx Pharma | 8-K: Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Vincerx Pharma | 10-K: Annual report
Vincerx Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Izumi Raquel E.
Vincerx Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Seelenberger Alexander A.
Vincerx Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hamdy Ahmed MD
Vincerx Pharma | 4: Statement of changes in beneficial ownership of securities-Officer THOMAS TOM C
No Data